⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALGS News
Aligos Therapeutics, Inc. Common Stock
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
ALGS
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
globenewswire.com
ALGS
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
globenewswire.com
ALGS
Allegis Launches SafeAxis™ Architectural-Grade Panic Hardware Engineered for Large Industrial Enclosures
prnewswire.com
ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ALGS
AlgoSec Security Management Solution A33.20 removes network security change friction across hybrid and multi-cloud networks
globenewswire.com
ALGS
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
globenewswire.com
ALGS
7MM Chronic Hepatitis B Therapeutics Market Drug Forecast and Market Analysis Report 2024-2034: Addressing Unmet Needs, Late-Stage Pipelines and Functional Cure Therapies Drive Growth
globenewswire.com
GSK
GILD
ALGS
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
globenewswire.com
ALGS
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
globenewswire.com
ALGS
JNJ